XML 80 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash $ 7,405 $ 25,934
Trade accounts receivable, net of allowance for doubtful accounts of $324 and $296, respectively 30,106 16,015
Inventories, net 29,759 22,843
Prepaid expenses and other current assets 3,103 2,368
Total current assets 70,373 67,160
Property, plant and equipment, net 22,525 10,744
Goodwill 26,753 20,109
Other intangible assets, net 9,721 6,504
Deferred tax assets 13,222 15,444
Other noncurrent assets 1,963 887
Total assets 144,557 120,848
Current Liabilities:    
Accounts payable 9,388 9,919
Current portion of long-term debt 1,372
Accrued compensation and related benefits 1,655 1,494
Accrued expenses and other current liabilities 4,775 3,973
Total current liabilities 17,190 15,386
Long-term debt 15,780
Deferred income taxes 559 591
Other noncurrent liabilities 1,278 408
Total liabilities 34,807 16,385
Commitments and contingencies (Note 6)
Shareholders' Equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,268,050 shares and 20,053,335 shares, respectively; outstanding – 15,866,868 shares and 15,920,585 shares, respectively 2,026 2,005
Capital in excess of par value 184,292 182,630
Accumulated deficit (52,830) (58,035)
Accumulated other comprehensive loss (2,531) (2,786)
Treasury stock - at cost; 4,401,182 shares and 4,132,750 shares, respectively (21,231) (19,266)
Total Ultralife Corporation equity 109,726 104,548
Non-controlling interest 24 (85)
Total shareholders’ equity 109,750 104,463
Total liabilities and shareholders' equity $ 144,557 $ 120,848